Mark Shlapobersky

Viral encephalitis of tilapia larvae: Primary characterization of a novel herpes-like virus

Mark Shlapobersky, Michael S. Sinyakov, Mark Katzenellenbogen et al. · Virology · 2010 · 64 citations

Pathogenesis, Viral Pathogenesis, Immunology +8

A Vaxfectin®-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes

Ronald L. Veselenak, Mark Shlapobersky, Richard B. Pyles et al. · Vaccine · 2012 · 59 citations · Full text

Vaccination, Vaccine Development, Therapeutic Use +10

Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer

Bar Kaufman, Orli Abramov, Anna Ievko et al. · Science Advances · 2023 · 38 citations · Full text

Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection

Mark Shlapobersky, Joshua O. Marshak, Lichun Dong et al. · Journal of General Virology · 2012 · 34 citations

Immunology, Immunodominance, Immunotherapeutics +16

Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines

Jukka Hartikka, Vesselina Bozoukova, Catherine K. Yang et al. · Vaccine · 2009 · 24 citations

Vaccination, Cationic Lipid-based Adjuvant, Immunology +6